High endothelial venules predict response to PD-1 inhibitors combined with anti-angiogenesis therapy in NSCLC

Tumor-associated high endothelial venules (TA-HEVs) mediate lymphocyte entry into tumors. Therefore, combined anti-angiogenesis therapy and programmed death-1 (PD-1) inhibitors might stimulate tumor immunity. This study will explore the TA-HEVs and real-world data of the combination therapy in non-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Dafu, Jin, Yao, Weng, Yiming, Cui, Xue, Wang, Jinsong, Peng, Min, Song, Qibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543372/
https://www.ncbi.nlm.nih.gov/pubmed/37777573
http://dx.doi.org/10.1038/s41598-023-43122-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543372/
https://www.ncbi.nlm.nih.gov/pubmed/37777573
http://dx.doi.org/10.1038/s41598-023-43122-w

Ejemplares similares